Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia (2011)
- Authors:
- USP affiliated authors: DOREA, EGIDIO LIMA - HU ; BERNIK, MARCIA MARTINS SILVEIRA - HU ; HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: HU; FCF
- Subjects: DISLIPIDEMIAS; HIPERCOLESTEROLEMIA; ARTERIOSCLEROSE
- Language: Inglês
- Imprenta:
- Publisher: Sociedade Brasileira de Genética (SBG)
- Publisher place: Ribeirão Preto
- Date published: 2011
- Source:
- Conference titles: Congresso Brasileiro de Genética
-
ABNT
RODRIGUES, Alice Cristina et al. Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia. 2011, Anais.. Ribeirão Preto: Sociedade Brasileira de Genética (SBG), 2011. . Acesso em: 14 fev. 2026. -
APA
Rodrigues, A. C., Sobrino, B., Genvigir, F. D. V., Willrich, M. A. V., Arazi, S. S., Dórea, E. L., et al. (2011). Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia. In Resumos. Ribeirão Preto: Sociedade Brasileira de Genética (SBG). -
NLM
Rodrigues AC, Sobrino B, Genvigir FDV, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Brion MJ, Carracedo A, Hirata MH, Hirata RDC. Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia. Resumos. 2011 ;[citado 2026 fev. 14 ] -
Vancouver
Rodrigues AC, Sobrino B, Genvigir FDV, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Brion MJ, Carracedo A, Hirata MH, Hirata RDC. Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia. Resumos. 2011 ;[citado 2026 fev. 14 ] - Polimorfismos no receptor scavenger classe B tipo I e sua relação com perfil sérico e resposta a atorvastatina em indivíduos brasileiros
- Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response
- Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals
- mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy
- CYP3A5 polymorphism is associated with differences on gene expression and cholesterol-lowering response to atorvastatin
- Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients
- Alteration of the expression of efflux and uptake transporters during hypercholesterolemia. Role in variability of atorvastatin response
- Estudo da expressão gênica e polimorfismos da CYP3A5 em indivíduos hipercolesterolêmicos tratados com atorvastatina
- Efeito da atorvastatina sobre os genes SREBF1, SREBF2 e SCAP em pacientes hipercolesterolêmicos
- Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
